Psychopharmacology in adolescent medicine

Adolescent Medicine Clinics

Volumn 17, Issue 1, 2006, Pages 165-181

  Scharf, Michael A ^a   Williams, Thomas P ^b  

^a UNIVERSITY OF ROCHESTER SCHOOL OF MEDICINE AND DENTISTRY   (United States)

^b Southview Commons   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PSYCHOTROPIC AGENT;

ADOLESCENT; CHILD PSYCHIATRY; COMPARATIVE STUDY; DOSE RESPONSE; DRUG ADMINISTRATION; FEMALE; HUMAN; MALE; MEDICINE; MENTAL DISEASE; METHODOLOGY; MOOD DISORDER; PSYCHOPHARMACOLOGY; REVIEW; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY;

ADOLESCENT; ADOLESCENT MEDICINE; ADOLESCENT PSYCHIATRY; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; FEMALE; HUMANS; MALE; MENTAL DISORDERS; MOOD DISORDERS; PSYCHOPHARMACOLOGY; PSYCHOTROPIC DRUGS; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY;

EID: 32244442034     PISSN: 15473368     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.admecli.2005.10.004     Document Type: Review

References (48)

1. H.A. Pincus, T.L. Tanielian, and S.C. Marcus Prescribing trends in psychotropic medications: primary care, psychiatry, and other medical specialties JAMA 279 7 1998 526 531
2. I.C. Wong, M.L. Murray, and D. Camilleri-Novak Increased prescribing trends of paediatric psychotropic medications Arch Dis Child 89 12 2004 1131 1132
3. M. Mickus, C.C. Colenda, and A.J. Hogan Knowledge of mental health benefits and preferences for type of mental health providers among the general public Psychiatr Serv 51 2 2000 199 202
4. W.J. Kim The American Academy of Child and Adolescent Psychiatry Task Force on Workforce Needs Child and adolescent psychiatry workforce: a critical shortage and national challenge Acad Psychiatry 27 4 2003 277 282
5. G.V. Gray, D.S. Brody, and M.T. Hart Primary care and the de facto mental health care system: improving care where it counts Manag Care Interface 13 3 2000 62 65
6. E.L. Liebelt, S.R. Daniels, and M.K. Farrell Evaluation of pediatric training by the alumni of a residency program Pediatrics 91 2 1993 360 364
7. R. Blum Physicians' assessment of deficiencies and desire for training in adolescent care J Med Educ 62 5 1987 401 407
8. J. Licinio, and M.L. Wong Depression, antidepressants and suicidality: a critical appraisal Nat Rev Drug Discov 4 2 2005 165 171
9. M.F. Hollon Direct-to-consumer marketing of prescription drugs: a current perspective for neurologists and psychiatrists CNS Drugs 18 2 2004 69 77
10. J. Lexchin How patient outcomes are reported in drug advertisements Can Fam Physician 45 1999 1213 1216
11. American Psychiatric Association Diagnostic and statistical manual of mental disorders 4th edition. Text revision 2000 American Psychiatric Association Washington (DC)
12. G.L. Engel The need for a new medical model: a challenge for biomedicine Science 196 4286 1977 129 136
13. P.W. Corrigan, B.D. Lurie, and H.H. Goldman How adolescents perceive the stigma of mental illness and alcohol abuse Psychiatr Serv 56 5 2005 544 550
14. H.V. Krell, A.F. Leuchter, and M. Morgan Subject expectations of treatment effectiveness and outcome of treatment with an experimental antidepressant J Clin Psychiatry 65 9 2004 1174 1179
15. J. Moncrieff, S. Wessely, and R. Hardy Active placebos versus antidepressants for depression Cochrane Database of Systematic Reviews 1 2004 CD003012
16. B.D. Beitman, M.R. Goldfried, and J.C. Norcross The movement toward integrating the psychotherapies: an overview Am J Psychiatry 146 2 1989 138 147
17. J.L. Cutler, A. Goldyne, and J.C. Markowitz Comparing cognitive behavior therapy, interpersonal psychotherapy, and psychodynamic psychotherapy Am J Psychiatry 161 9 2004 1567 1573
18. J.A. Lazarus Ethics in split treatment Psychiatr Ann 31 10 2001 611 614
19. J. McClellan, and J. Werry Practice parameter for the assessment and treatment of children and adolescents with schizophrenia. American Academy of Child and Adolescent Psychiatry J Am Acad Child Adolesc Psychiatry 40 7 Suppl 2001 4S 23S
20. J. McClellan, and J. Werry Practice parameters for the assessment and treatment of children and adolescents with bipolar disorder. American Academy of Child and Adolescent Psychiatry J Am Acad Child Adolesc Psychiatry 36 10 Suppl 1997 157S 176S
21. J.S. March, and J.F. Curry Predicting the outcome of treatment J Abnorm Child Psychol 26 1 1998 39 51
22. M.J. Dewan Adding medications to ongoing psychotherapy: indications and pitfalls Am J Psychother 46 1 1992 102 110
23. M.C. Tosyali, and L.L. Greenhill Child and adolescent psychopharmacology. Important developmental issues Ped Clin North Am 45 5 1998 1021 1035
24. M.G. Ziegler, C.R. Lake, and I.J. Kopin Plasma norepinephrine increases with age Nature 261 1976 333 335
25. N.D. Ryan Pharmacotherapy of adolescent major depression: beyond TCAs Psychopharmacol Bull 26 1990 75 79
26. B. Birmaher, D.A. Brent, and R.S. Benson Summary of the practice parameters for the assessment and treatment of children and adolescents with depressive disorders. American Academy of Child and Adolescent Psychiatry J Am Acad Child Adolesc Psychiatry 37 11 1998 1234 1238
27. T.P. Williams, and B.D. Miller Pharmacologic management of anxiety disorders in children and adolescents Curr Opin Pediatr 15 5 2003 483 490
28. C.W. Popper Antidepressants in the treatment of attention-deficit/ hyperactivity disorder J Clin Psychiatry 58(Suppl)14 1997 14 29
29. C.K. Varley, and C.J. Smith Anxiety disorders in the child and teen Pediatr Clin North Am 50 5 2003 1107 1138
30. G.A. Keepers, and D.E. Casey Prediction of neuroleptic induced dystonia J Clin Psychopharm 7 1987 342 345
31. H. Golombek, and S. Kutcher Feeling states during adolescence Psych Clin North Am 13 3 1990 443 454
32. D.M. Vukadinovich Minors' rights to consent to treatment: navigating the complexity of state laws J Health Law 37 4 2004 667 691
33. A. English Treating adolescents. Legal and ethical considerations Med Clin North Am 74 5 1990 1097 1112
34. B. Judge, and S.B. Billick Suicidality in adolescence: review and legal considerations Behav Sci Law 22 5 2004 681 695
35. Physician's desk reference 59th edition 2004 Thomson Healthcare Montvale, New Jersey
36. D.A. Brent Antidepressants and pediatric depression-the risk of doing nothing N Engl J Med 351 16 2004 1598 1601
37. R.J. Valuck, A.M. Libby, and M.R. Sills Antidepressant treatment and risk of suicide attempt by adolescents with major depressive disorder: a propensity-adjusted retrospective cohort study CNS Drugs 18 15 2004 1119 1132
38. H. Jick, J.A. Kaye, and S.S. Jick Antidepressants and the risk of suicidal behaviors JAMA 292 3 2004 338 343
39. J. Angst Major depression in 1998: are we providing optimal therapy? J Clin Psychiatry 60 Suppl 6 1999 5 9
40. G.A. Carlson Early onset bipolar disorder: clinical and research considerations J Clin Child Adolesc Psychol 34 2 2005 333 343
41. G.A. Bernstein, and K. Shaw Practice parameters for the assessment and treatment of children and adolescents with anxiety disorders. American Academy of Child and Adolescent Psychiatry J Am Acad Child Adolesc Psychiatry 36 10 Suppl 1997 69S 84S
42. C.U. Correll, S. Leucht, and J.M. Kane Lower risk for tardive dyskinesia associated with second-generation antipsychotics: a systematic review of 1-year studies Am J Psychiatry 161 3 2004 414 425
43. J.W. Newcomer Second-generation (atypical) antipsychotics and metabolic effects: a comprehensive literature review CNS Drugs 19 Suppl 1 2005 1 93
44. American Diabetes Association American Psychiatric Association American Association of Clinical Endocrinologists North American Association for the Study of Obesity Consensus development conference on antipsychotic drugs and obesity and diabetes Diabetes Care 27 2 2004 596 601
45. American Psychiatric Association Practice guideline for the treatment of patients with eating disorders (revision). American Psychiatric Association Work Group on Eating Disorders Am J Psychiatry 157 1 Suppl 2000 1 39
46. F. Volkmar, E.H. Cook Jr, and J. Pomeroy Practice parameters for the assessment and treatment of children, adolescents, and adults with autism and other pervasive developmental disorders. American Academy of Child and Adolescent Psychiatry Working Group on Quality Issues J Am Acad Child Adolesc Psychiatry 38 12 Suppl 1999 32S 54S
47. M. Dulcan Practice parameters for the assessment and treatment of children, adolescents, and adults with attention-deficit/hyperactivity disorder. American Academy of Child and Adolescent Psychiatry J Am Acad Child Adolesc Psychiatry 36 10 Suppl 1997 85S 121S
48. H. Steiner Practice parameters for the assessment and treatment of children and adolescents with conduct disorder. American Academy of Child and Adolescent Psychiatry J Am Acad Child Adolesc Psychiatry 36 10 Suppl 1997 122S 139S